Skip to main navigation Skip to search Skip to main content

Do patients benefit from switching to a second biologic drug when the first is withdrawn due to lack of efficacy or adverse events?

Elisabeth Hjardem, Mikkel Østergaard, M.L. Hetland

Original languageEnglish
Publication date2004
Publication statusPublished - 2004
EventArthritis Rheum -
Duration: 18 Jul 2011 → …

Conference

ConferenceArthritis Rheum
Period18/07/2011 → …

Cite this